ECONOMYNEXT – Sri Lanka’s J L Morisons Son & Jones (Ceylon) PLC said it plans to invest $13.5 million to build a new pharmaceutical manufacturing plant.
The company, a unit of the Hemas Holdings group, said in a stock exchange filing that commercial operations of the plant are expected to start in 2019.
“This research and manufacturing facility will be located within the Sri Lanka Institute of Nanotechnology park in Pitipana, Homagama,” it said. “The proposed plant will significantly enhance the manufacturing capacity of the company, while complying with global regulatory standards.”
The company, a unit of the Hemas Holdings group, said in a stock exchange filing that commercial operations of the plant are expected to start in 2019.
“This research and manufacturing facility will be located within the Sri Lanka Institute of Nanotechnology park in Pitipana, Homagama,” it said. “The proposed plant will significantly enhance the manufacturing capacity of the company, while complying with global regulatory standards.”
No comments:
Post a Comment